Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by tylerreddickon Mar 13, 2024 3:50pm
107 Views
Post# 35931230

RE:RE:RE:RE:RE:New Press Release - Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations

RE:RE:RE:RE:RE:New Press Release - Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations
biorun wrote: 1067 my good buddy is licensed globally and with an organization far more competent and resources than Sirona to bring to market.

Like I said, if one believes that Allergan will get to market, then 8 cents is a bargain, if you don't well then 8 cents is a fair assessment.

As for you, you keep promising to put me on ignore but you simply can't stick to your word. How about you start now?


You will note that I hadn't responded to your drivel for quite some time, as I did have you on ignore.
I took you off today just to see if anything has changed, and no, it hasn't. All you post is mindless word salad. And you don't support the share price with buying, even when it is "cheap" in your "expert" opinion. 

So yes, you can quite easily go back on ignore. Bye bye.
<< Previous
Bullboard Posts
Next >>